Blockade of CD73 delays glioblastoma growth by modulating the immune environment
This study indicates that CD73 knockdown using a nanotechnological approach to perform nasal delivery of siRNA-CD73 to CNS can potentially regulate the glioblastoma immune microenvironment and delay tumor growth by inducing apoptosis.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research
More News: Allergy & Immunology | Brain Tumor | Cancer | Cancer & Oncology | Environmental Health | Glioma | Immunotherapy | Nanotechnology | Study